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Abstract
Background: In type 1 diabetes (T1D) vascular complications such as accelerated atherosclerosis and diffused macro-/
microangiopathy are linked to chronic hyperglycemia with a mechanism that is not yet well understood. End-stage renal
disease (ESRD) worsens most diabetic complications, particularly, the risk of morbidity and mortality from cardiovascular
disease is increased several fold.
Methods and Findings: We evaluated protein regulation and expression in skin biopsies obtained from T1D patients with
and without ESRD, to identify pathways of persistent cellular changes linked to diabetic vascular disease. We therefore
examined pathways that may be normalized by restoration of normoglycemia with kidney-pancreas (KP) transplantation.
Using proteomic and ultrastructural approaches, multiple alterations in the expression of proteins involved in oxidative
stress (catalase, superoxide dismutase 1, Hsp27, Hsp60, ATP synthase d chain, and flavin reductase), aerobic and anaerobic
glycolysis (ACBP, pyruvate kinase muscle isozyme, and phosphoglycerate kinase 1), and intracellular signaling (stratifin-14-3-
3, S100-calcyclin, cathepsin, and PPI rotamase) as well as endothelial vascular abnormalities were identified in T1D and
T1D+ESRD patients. These abnormalities were reversed after KP transplant. Increased plasma levels of malondialdehyde
were observed in T1D and T1D+ESRD patients, confirming increased oxidative stress which was normalized after KP
transplant.
Conclusions: Our data suggests persistent cellular changes of anti-oxidative machinery and of aerobic/anaerobic glycolysis
are present in T1D and T1D+ESRD patients, and these abnormalities may play a key role in the pathogenesis of
hyperglycemia-related vascular complications. Restoration of normoglycemia and removal of uremia with KP transplant can
correct these abnormalities. Some of these identified pathways may become potential therapeutic targets for a new
generation of drugs.
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Introduction
In type 1 diabetes mellitus (T1D), chronic hyperglycemia leads
to the development of both microvascular and macrovascular
complications [1,2]. The Diabetes Control and Complications
Trial (DCCT) determined the effect of improved metabolic control
in patients with T1D on the development of diabetic complica-
tions, such as diabetic retinopathy, nephropathy, neuropathy, and
cardiovascular diseases [3]. In a cohort of patients treated with
intensive diabetes management, there was a persistent decrease in
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the incidence of progression in retinopathy as well as of
cardiovascular diseases [3,4].
Experimental data from animal and cellular models have led to
several hypotheses on the mechanisms that may link chronic
hyperglycemia and diabetic complications, but these hypotheses
still have a level of uncertainty with regards to their applicability
and significance in explaining complications in patients affected by
T1D [2]. The four main mechanisms that may explain how
chronic hyperglycemia may induce diabetic complications are: 1)
an increase in polyol pathway flux; 2) an increase in advanced
glycation end-product formation; 3) an activation of protein kinase
C isoforms; and 4) an increase in hexosamine pathway flux [2,3,5].
It has been suggested that each of these pathogenic mechanisms
may reflect a single hyperglycemia-induced process, specifically,
the overproduction of superoxide by the mitochondrial electron-
transport chain [5,6]. It has also been suggested that oxidative
stress, which may induce protein modifications altering their
activity or function, may accelerate the basic pathogenic processes
of diabetic complications [5,6,7]. Several major forms of oxidative
modifications can occur on amino acid residue side chains,
including carbonylation, nitrosylation, and oxidation of methio-
nine to methionine sulfoxide [8]. However, supportive evidence
from large clinical trials that shows antioxidants can ameliorate
diabetic complications is lacking [3].
Pancreas transplantation is the only treatment in T1D that can
restore long-term insulin independence and normoglycemia
[9,10]. In most cases, pancreas transplantation is associated with
kidney transplantation in T1D with end-stage renal disease
(ESRD). Although these patients need lifelong immunosuppres-
sion, successful kidney-pancreas (KP) transplantation can achieve
insulin independence as well as a dialysis-free state [9,10,11,12].
The survival rate is almost doubled in KP transplant patients
compared with T1D+ESRD patients on the waiting list for a
transplant [10,13]. Interestingly, ultrastructural features of endo-
thelial damage in skin biopsy specimens showed improved profiles
in patients who received a successful KP transplant [14].
Proteomics is the combination of two-dimensional polyacryl-
amide gel electrophoresis (2D PAGE) for protein separation and
visualization, followed by mass spectrometric (MS) protein
identification using peptide mass fingerprints and tandem MS
peptide sequencing [15]. Differential protein expression profiles
detected by 2D PAGE and MS have been reported for various
types of human diseases and have offered opportunities in
identifying new markers and therapeutic targets and new
insights in understanding disease pathogenesis [16,17]. In
recent years, the number of novel proteins identified by
genomic and proteomic research projects has dramatically
increased, with a concomitant more rapid characterization of
molecular processes of living cells through large-scale studies in
specific biological contexts. We reasoned that the proteomic
approach might offer a powerful tool to assess differences in
protein expression associated with diabetes and renal compli-
cations, as few papers have described the use of this technique in
diabetes [18,19].
Our aim was to study the regulation of protein expression in
skin biopsies of patients with T1D and T1D+ESRD, to identify
pathways of persistent cellular changes and damage, and to
evaluate the effects of restoration of normoglycemia obtained with
kidney-pancreas transplantation on these pathways. To this end,
we performed two-dimensional electrophoresis and mass spec-
trometry comparing skin biopsy extracts from the following four
groups of patients: controls, T1D, T1D+ESRD, and KP
transplanted patients. Proteomic results were integrated with
morphological, immunohistochemical, and ultrastructural features
of skin tissues of all the patients included in the study. This
approach will lead to identification of pathways that can
potentially become targets for new class of drugs to control
cellular changes associated with vascular abnormalities.
Materials and Methods
Ethics Statement
All subjects gave their written informed consent to the study,
which was approved by the Ethics Committee of San Raffaele
Scientific Institute.
Table 1. Clinical and laboratory characteristics of the patients enrolled in the study.
Controls T1D T1D+ESRD KP
Sex (M/F) 7/4 6/5 11/7 11/7
Age (years) 39.465.1 37.762.7 36.262.1 40.162.8
HbA1c (%) 4.860.1 7.060.5* 8.360.5* 5.160.2
C-peptide (ng/ml) 1.260.1 0.160.1* 0.160.1* 3.060.4*
Creatinine (mg/dl) 1.160.2 0.960.2 8.360.4* 1.460.1
Insulin (m IU/ml) 5.162.5 10.361.9* 26.967.1* 14.961.4*
BMI (Kg/m2) 25.160.5 23.161.0 22.660.5 24.660.6
HOMA index 2.360.1 2.960.4 6.461.6* 3.160.3*
T1D duration (years) / 25.461.1 27.361.4 24.561.2
Transplant duration (years) / / / 5.661.1
Retinopathy 0/11 11/11 17/18 18/18
Nephropathy 0/11 3/11 18/18 18/18
Neuropathy 0/11 11/11 18/18 18/18
Cardio-cerebro-vascular diseases 0/11 0/11 2/18 3/18
*: statistical significance (p,0.05) versus control; T1D (type 1 diabetic patients); T1D+ESRD (T1D+end-stage renal disease); KP (kidney-pancreas transplanted patients);
HbA1c (glycated hemoglobin); BMI (body mass index); HOMA (homeostatic model assessment).
doi:10.1371/journal.pone.0009923.t001
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Patients and Study Design
The study included 11 patients with T1D, 18 with T1D+ESRD,
18 with ESRD who received a simultaneous KP transplant, and 11
healthy subjects (controls).
The study was conducted from June 2000 to June 2004 and all
of the transplanted patients that were consecutively admitted to
the San Raffaele Hospital in Milan, Italy for the standard check-up
were included in the study if they met the inclusion criteria. Only
those transplanted patients with a follow-up longer than one year
and acceptable graft function were included in the study. Patients
with clear signs of systemic infection, lymphoproliferative disease,
urinary infection, enhanced erythrocyte sedimentation velocity/C
reactive protein were excluded, as well as patients taking oral
anticoagulants. Subjects in the four groups were matched for age,
gender, diabetes, and dialysis duration (when performed). KP
transplant patients were all insulin independent, whereas the T1D
and T1D+ESRD patients were on intensive subcutaneous insulin
therapy. All of the patients included in the T1D+ESRD and KP
groups were on anti-platelet therapy (80% ASA and 20%
ticlopidine) to prevent graft or fistula thrombosis. In hemodialyzed
patients, blood samples were collected before undergoing dialysis
to avoid the confounding effect mediated by heparin administra-
tion and by the contact with hemodialysis membrane.
Table 1 displays the laboratory and clinical characteristics of
patients. All investigations were performed on skin biopsies
obtained from patients by skin-punch biopsy of the internal
surface of the arm [20,21].
Transplantation and Immunosuppression
Organs for transplantation were obtained from deceased donors
through the ‘‘North Italia Transplant’’ organ procurement
consortium (NITp, Milan, Italy). After induction with ATG
(thymoglobulin, IMTIX, SANGSTAT), immunosuppression was
maintained using cyclosporine (through levels between 100–
250 ng/ml) or FK506 (through levels between 10–15 ng/ml),
mycophenolate mofetil (500–2000 mg/day), and methylpredniso-
lone (10 mg/day). Steroids were withdrawn within 3–6 months
after transplantation. Episodes of kidney rejection were treated
with pulses of 500 mg of methylprednisolone. Cases of ‘‘steroid-
resistant’’ rejection were treated with OKT3 or a course of ATG.
2D-Electrophoresis
Tissues were homogenized in a lysis buffer consisting of 10 mM
Hepes, 1% Triton X-100, and protease inhibitor cocktail, including
aprotinin, leupeptin, pepstatin A, Bestatin, E-64, AEBSF, PMSF, or
benzamidine (Sigma) (10 ml/ml). Proteins were extracted at 4uC,
protein concentration was determined using the Bio-Rad protein
assay, and pools of two biopsies were made for each experiment. For
the 2D-polyacrylamide gels, 250 mg of extract were precipitated
with four volumes of acetone and resuspended in a running buffer
Figure 1. Typical silver-stained 2D electrophoresis pattern of proteins isolated from human skin biopsies in the broad nonlinear pH
range 3–10. Skin biopsies were obtained from controls, patients affected by type 1 diabetes (T1D), patients affected by T1D and end-stage renal
disease (T1D+ESRD), and kidney-pancreas transplanted patients (KP).
doi:10.1371/journal.pone.0009923.g001
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consisting of 8 M urea, 4% CHAPS, 65 mMDTT, BFB 0.05% (w/
v), and IPG buffer 1.7% (v/v). Samples of 100 mg were analyzed by
2D IEF/SDS–PAGE Immobiline IPG strips DryStrips (18 cm 3–
10 pH non-linear, Amersham Biosciences) on an IPGphor
apparatus according to the manufacturer’s instructions (Amersham
Biosciences). After rehydration (1 hour at 18uC) of the IPG strip and
absorption of the sample (30 V, for 8 hours at 18uC), isoelectric
focusing was performed using a voltage gradient from 300 to
3,500 V for three hours, followed by 3,500 V for another three
hours (according to the manufacturer’s instructions). For the second
dimension, the IPG strip was equilibrated for 15 minutes in
equilibration buffer containing DTT 2% w/v and then for 15
minutes in equilibration buffer containing iodoacetamide 2.5% w/v
(equilibration buffer consisted of urea 6 M, glycerol 30% v/v, SDS
2% w/v, and 50 mM Tris/HCl pH 8.8). Protein separation in the
second dimension was performed in gradient (9%–16.5%) poly-
acrylamide gels. Theses gels were fixed twice in two solutions
containing different concentrations of methanol and acetic acid
(40%methanol/10% acetic acid; 5%methanol/5% acetic acid) and
then washed with deionized water (3620minutes). The sensitization
step was performed with 0.02% sodium thiosolphate. After two
washing steps (1 minute 62), the gels were stained with silver-
staining solution without glutaraldehyde (0.1% silver nitrate) and
then washed for one minute with deionized water. The gels were
developed in a solution containing 2.5% Na2CO3, 0.008%
formaldehyde. Reaction was stopped with 5% acetic acid [22].
An Image Scanner was used to scan the gels and then they were
analyzed with Image Master 2D Elite software (Amersham
Biosciences). Protein expression in diabetic and transplanted
patients was normalized with healthy controls. Protein expression
in diabetic and transplanted patients was normalized with healthy
controls as 100% in the case of down-regulated proteins, or with
diabetic and diabetic-uremic patients at 100% in the case of proteins
that were up-regulated in these patients’ categories. Nine indepen-
dent experiments were performed with pools of proteins from
various skin donors.
Protein Identification by MALDI-TOF MS Analysis
Spots of interest were excised from silver-stained gels either
by manual or automated excision (ProXCISION; PerkinElmer),
Table 2. Proteins identified by MALDI-TOF-MS analysis.
SwissProt accession no. PROTEIN Measured peptides Matched peptides Seq. cov. %
P02768 albumin 13 11 22
P01922 hemoglobin/Hemoglobin alpha chain 7 4 35
P13645 keratin 16 7 11
P01009 anti-trypsin precursor protein 27 13 25
P07108 Acyl-coa-binding protein (ACBP) 14 5 47
P04217 Alpha 1b-glycoprotein precursor 11 8 26
P02652 Apolipoprotein A-II precursor 13 4 27
P06576 ATP synthase d chain 59 28 47
O75947 ATP synthase d chain 11 6 34
P06703 Calcyclin; S100 calcium-binding protein A6 20 11 51
Q9NZT1 Calmodulin-like skin protein 7 6 42
P04040 Catalase 14 13 39
P07339 Cathepsin D 10 7 15
P02787 Serotransferrin 9 6 9
P06733 Enolase 1 (Phosphopyruvate hydratase) 23 22 52
P10768 Esterase d 9 6 34
P04792 Heat shock protein 27 kda 14 10 48
P10809 Heat shock protein 60 kda 47 32 54
P30043 NADPH-flavin reductase 16 11 67
P05092 Peptidyl-prolyl cis-trans isomerase A (Rotamase) 15 9 39
P32119 Peroxiredoxin 2 9 8 40
P30044 Peroxiredoxin-5, mitochondrial; 27 7 50
P06733 2-phosphopyruvate-hydratase alpha-enolase 5 5 15
P00558 Phosphoglycerate kinase 1 7 5 21
P02647 Proapolipoprotein 39 30 80
P14618 Pyruvate kinase muscle isozyme 14 8 14
P31947 Stratifin 17 9 29
P00441 Superoxide dismutase-1 9 5 40
P02766 Transthyretin precursor 8 6 50
P02766 Transthyretin precursor 8 5 53
P00938 Triosephosphate isomerase 1 33 15 69
doi:10.1371/journal.pone.0009923.t002
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reduced, alkylated, and digested overnight with bovine trypsin
(Roche), as previously described [23,24]. One micro-liter
aliquots of the supernatant were used for MALDI-TOF MS
analysis (Voyager-DE STR from Applied Biosystem, Framing-
ham, MA), using the dried droplet technique and cyano-4-
hydroxycinnamic acid as matrix. Alternatively, gel fragments
were further extracted and the resulting peptide mixture was
subjected to a single desalting/concentration step before the
mass spectrometric analysis over mZipTipC18 (Millipore Cor-
poration, Bedford, MA). MALDI-TOF spectra were internally
calibrated using trypsin autolysis products and processed via
Data Explorer software. Proteins were unambiguously identi-
fied by searching in the comprehensive non-redundant protein
database with the program ProFound [16,17]. One missed
cleavage per peptide was allowed, and an initial mass tolerance
of 50 ppm was used in all searches.
Statistical Analysis
Data were analyzed using SPSS statistical package for Windows,
10.1 (SPSS Inc., Chicago, IL). Quantitative data were expressed as
mean 6 standard error and were tested for normal distribution
with the Kolmogorov-Smirnov test and for homogeneity of
variances with Levene’s test. When more than two groups were
compared cross-sectionally, ANOVA (for parametric data) or
Kruskal-Wallis test (for non-parametric data) was used according
to distribution. When ANOVA was used, multiple post-hoc
comparison analysis was performed with Tukey’s test. A P value of
less than 0.05 (by two-tailed testing) was considered of statistical
significance. Further information concerning the materials/
instruments utilized, antibodies used to characterize skin biopsy
specimens, pathway analysis, immunohistochemistry, electron
microscopy, and the malondialdehyde and GSH quantification
can be found in the Supporting Information [File S1].
Figure 2. Densitometric quantitation of differential protein expression in controls and type 1 diabetic patients (T1D). Representative
protein spots from 2D gels are inserted above each bar chart. SOD1 expression was increased by 2.5-fold and ATP synthase d chain 2-fold in T1D
compared with controls (p,0.01) (A). HSP27 and HSP60 were both up-regulated in T1D patients compared with controls (p,0.01) (A). Pyruvate
kinase (10-fold) (p,0.001) and ACBP (2-fold) (p,0.01) expression in T1D patients was up-regulated compared with controls (B); while stratifin was not
detectable in control patients and highly expressed in both T1D groups (p,0.001) (C). S100-calcyclin and rotamase expression was up-regulated by
2-fold in T1D compared with controls (p,0.05) (C). However, T1D showed a decrease in phosphoglycerate kinase and catalase expression compared
with controls (p,0.05) (A, B). Flavin and Cathepsin are unchanged (A, C).
doi:10.1371/journal.pone.0009923.g002
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Results
Proteomic analysis revealed alterations in three major
groups of proteins in T1D and T1D+ESRD patients
We extracted proteins from skin biopsies of the four groups and
performed two-dimensional electrophoresis comparing skin biopsy
extracts of healthy control subjects, T1D, T1D+ESRD, and KP
transplant patients. Figure 1 shows a typical silver-stained 2D
electrophoresis pattern of proteins isolated from human skin
biopsies in the broad non-linear pH range 3–10. In each gel
approximately 200 silver-stained spots were detected, matched, and
quantified using image analysis software (Image Master software,
Amersham Biosciences). We evaluated the total number of spots in
the gels observing high reproducibility of all the experiments
performed and high similarity of the gels in each experiment. The
results were processed and the expression of albumin and keratin
was quantified as a positive control. These proteins presented
comparable expression in the four groups of patients (data not
shown). However, the analysis with Image Master 2D Elite software
emphasized that there were some spots differentially expressed in
T1D+ESRD and T1D compared with the controls. These spots
were subjected to tryptic digestion and mass spectrometric analysis
in order to identify the proteins. MALDI-TOF-MS analysis
revealed that 19.5% was albumin, 5.4% hemoglobin, 3.3% keratin,
and 6.5% anti-trypsin precursor protein. The remaining 65.3% are
listed in Table 2. A number of proteins were not identified because
Figure 3. Densitometric quantitation of differential protein expression in controls, type 1 diabetic patients with end-stage renal
disease (T1D+ESRD), and kidney-pancreas transplanted patients (KP). Representative protein spots from 2D gels are inserted above each
bar chart. SOD1 expression was increased by 5-fold in T1D+ESRD patients compared with controls (p,0.01). KP transplantation was shown to reduce
by 2-fold this up-regulation (KP vs. T1D+ESRD and vs. controls, p,0.01 and p,0.05, respectively) (A). HSP27 expression was increased in T1D+ESRD
patients compared with controls (p,0.01), and it was almost normalized in the KP group (KP vs. T1D+ESRD p,0.05). HSP60 expression was increased
more than 2-fold in T1D+ESRD group compared with controls (p,0.01) and normalized in KP patients (KP vs. T1D+ESRD p,0.01) (A). ATP-synthase d
chain was 6-fold up-regulated in T1D+ESRD patients compared with controls (p,0.001) and was partially normalized in KP patients (KP vs. controls
and T1D+ESRD p,0.05 and p,0.01) (A). The expression of pyruvate kinase (B) and stratifin (C) was increased in T1D+ESRD patients compared with
controls (p,0.001). KP transplantation reduced the expression of pyruvate kinase (KP vs. T1D+ESRD p,0.05) and stratifin (KP vs. controls p,0.01 and
vs. T1D+ESRD p,0.05) compared with T1D+ESRD. ACBP expression was increased by 3-fold in T1D+ESRD patients compared with controls (p,0.01)
while in KP group the levels normalized (B). S100-calcyclin expression was up-regulated by 2-fold (p,0.01 vs. controls), while rotamase and cathepsin
were unchanged (C). S100-calcyclin expression was normalized in KP group (p,0.05) (C). Catalase expression decreased 25-fold (p,0.001) (A) and
phosphoglycerate kinase 1 expression decreased 4-fold (p,0.01) (A) in T1D+ESRD group compared with controls. A clear reversal of
phosphoglycerate kinase 1 and partially of catalase expression abnormalities was observed after KP transplantation (p,0.05 and p,0.01 vs.
T1D+ESRD for phosphoglycerate kinase 1 and partially of catalase, respectively), (B). Flavin reductase expression was halved in T1D+ESRD compared
with controls (p,0.05), (A).
doi:10.1371/journal.pone.0009923.g003
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of insufficient material for the mass analysis and/or incomplete
correspondence in the protein databases. Only three groups of
proteins were significantly aberrantly expressed in T1D and
T1D+ESRD: (i) Protein linked to oxidative stress response (catalase,
superoxide dismutase 1/SOD-1, flavin reductase, HSP60, HSP27,
and ATP synthase d chain) (Figures 2A and 3A); (ii) protein linked to
aerobic and anaerobic glycolysis (ACBP, phosphoglycerate kinase 1
and pyruvate kinase muscle isozyme) (Figures 2B and 3B); and (iii)
protein related to intracellular signaling pathways (stratifin-14-3-3,
S100-calcyclin, cathepsin, and PPI rotamase), (Figures 2C and 3C).
Protein linked to oxidative stress response and aerobic/
anaerobic glycolysis are up-regulated in T1D and
T1D+ESRD patients compared with controls
(i) T1D vs. controls. We first evaluated the effect of long-
standing T1D on protein expression in the absence of ESRD,
which alone, can enhance oxidative stress. Skin biopsies obtained
from T1D patients with normal kidney function were subjected to
proteomic analysis. SOD-1 expression was increased 2.5-fold and
ATP synthase d chain 2-fold in T1D patients compared with
controls (p,0.01), (Figure 2A). HSP60 and HSP27 were both up-
regulated in T1D patients compared with controls (p,0.01),
(Figure 2A). Pyruvate kinase (10-fold) (p,0.001) and ACBP (2-
fold) (p,0.01) expression in T1D patients was up-regulated
compared with controls (Figure 2B); while stratifin was not
detectable in control patients it was highly expressed in T1D
(p,0.001), (Figure 2C). S100-calcyclin and rotamase expression
was up-regulated by 2-fold in T1D patients compared with
controls (p,0.05), (Figure 2C). On the other hand, T1D patients
showed a decrease in phosphoglycerate kinase and catalase
expression compared with controls (p,0.05), (Figures 2A and
2B). Cathepsin and flavin were unchanged (Figures 2A and 2C).
Figure 4. Immunohistochemical expression of Hsp27, Hsp60, ACBP, and S100 proteins in controls, patients affected by type 1
diabetes (T1D), type 1 diabetes+end-stage renal disease (T1D+ESRD), and kidney-pancreas transplanted patients (KP) skin
specimens. Hsp27 was strongly expressed in the cytoplasm of all epidermal cells without significant differences among the four categories of
patients (A1–A4). Endothelial cells of control, T1D, and T1D+ESRD patients were intensely immunoreactive for Hsp27 (B1–B3), while in KP patients the
endothelial Hsp27 immunoreactivity was weaker (B4). Hsp60 immunoreactivity was not found in the epidermal layer of control patients (C1), while it
was expressed in the epidermal cells of T1D, T1D+ESRD, and KP patients (C2–C4), although the intensity of the reaction was lower than that of Hsp27.
Hsp60 immunoreactivity was also found in endothelial cells of all patient groups, but the immunoreactivity was slightly more intense in control and
KP patients (D1, D4) than in T1D and T1D+ESRD patients (D2, D3). ACBP immunoreactivity was intense and diffuse in epidermal epithelial cells of all
four patient groups (E1–E4) without significant differences, while it was weaker in endothelial cells of the same patients (F1–F4). S100 protein
immunoreactivity was intense in dendritic Langerhans cells distributed among epithelial cells of the epidermal layer (G1–G4) and in nerves (H1–H4) of
all patients studied.
doi:10.1371/journal.pone.0009923.g004
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(ii) T1D+ESRD patients compared with controls and KP
transplant patients. We then evaluated the effect of T1D and
ESRD on protein expression and the effect of KP transplantation
with restoration of normoglycemia and the withdrawal of uremia.
SOD1 expression was increased by 5-fold in T1D+ESRD patients
compared with controls (p,0.01). KP transplantation led to a
reduction in the up-regulation of SOD1 expression by 2-fold (KP
vs. T1D+ESRD and vs. controls, p,0.01 and p,0.05,
respectively), (Figure 3A). HSP27 expression was increased in
T1D+ESRD patients compared with controls (p,0.01) and it was
almost normalized in the KP group (KP vs. T1D+ESRD p,0.05).
Hsp60 expression was increased more than 2-fold in T1D+ESRD
patients compared with controls (p,0.01) and was normalized in
KP patients (KP vs. T1D+ESRD p,0.01), (Figure 3A).
ATP-synthase d chain was 6-fold up-regulated in T1D+ESRD
patients compared with controls (p,0.001) and was partially
normalized in KP patients (KP vs. controls and T1D+ESRD
p,0.05 and p,0.01), (Figure 3A). The expression of pyruvate
kinase (Figure 3B) and stratifin (Figure 3C) was increased in
T1D+ESRD patients compared with controls (p,0.001). KP
transplantation reduced the expression of pyruvate kinase (KP vs.
T1D+ESRD p,0.05) and stratifin (KP vs. controls p,0.01 and vs.
T1D+ESRD p,0.05) compared with T1D+ESRD patients.
ACBP expression was increased by 3-fold in T1D+ESRD patients
compared with controls (p,0.01) while in the KP group the levels
normalized (Figure 3B). S100-calcyclin expression was up-
regulated by 2-fold (p,0.01 vs. controls), while rotamase and
cathepsin were unchanged (Figure 3C). S100-calcyclin expression
was completely normalized by KP transplant (p,0.05),
(Figure 3C). Three proteins were significantly down-regulated in
KP patients: catalase, phosphoglycerate kinase 1, and flavin
reductase. Catalase expression decreased about 25-fold (p,0.001),
(Figure 3A) and phosphoglycerate kinase 1 expression almost 4-
fold (p,0.01), (Figure 3B) in T1D+ESRD patients compared with
controls. A clear reversal of phosphoglycerate kinase 1 and
partially of catalase expression abnormalities was observed after
KP transplantation (p,0.05 and p,0.01 vs. T1D+ESRD for
phosphoglycerate kinase 1 and partially of catalase, respectively).
Flavin reductase expression was reduced by half in T1D+ESRD
patients compared with controls (p,0.05), with a near normali-
zation (ns vs. controls, Figure 3A).
By comparing the proteomic pattern in T1D and T1D+ESRD
patients, it appeared that protein expression abnormalities are
consistently present in both groups at a different degree. As
expected, ESRD increased the alterations of HSP and anti-
oxidative machinery in T1D.
Immunohistochemical and ultrastructural analysis
Although immunohistochemistry is not a quantitative method
able to differentiate protein levels in skin specimens among the
four categories studied (control, T1D, T1D+ESRD, KP patients),
it allowed us to exactly localize the HSP complex and oxidative
stress-related proteins in skin compartments (Figure 4 and Table 3).
Immunohistochemical expression of Hsp27, Hsp60, ACBP, and
S100 proteins was evaluated in control, T1D, T1D+ESRD, and
KP skin specimens. Hsp27 was strongly expressed in the cytoplasm
of all epidermal cells without significant differences among the four
categories of patients (Figures 4A1–4A4). Endothelial cells of
control, T1D, and T1D+ESRD patients were intensely immuno-
reactive for Hsp27 (Figures 4B1–4B3), while in KP patients the
endothelial Hsp27 immunoreactivity was moderate (Figure 4B4).
Hsp60 immunoreactivity was not found in the epidermal layer of
control patients (Figure 4C1), while it was expressed in the
epidermal cells of T1D, T1D+ESRD, and KP patients
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(Figures 4C2–4C4), although the intensity of the reaction was
lower than that of Hsp27. Hsp60 immunoreactivity was also found
in endothelial cells of all patient groups, but the immunoreactivity
was slightly more intense in control and KP patients (Figures 4D1
and 4D4) than in T1D and T1D+ESRD patients (Figures 4D2
and 4D3). ACBP immunoreactivity was intense and diffuse in
epidermal epithelial cells of all four patients groups (Figures 4E1–
4E4) without significant differences, while it was weaker in
endothelial cells of the same patients (Figures 4F1–4F4). S100
protein immunoreactivity was intense in dendritic Langerhans
cells distributed among epithelial cells of the epidermal layer
(Figures 4G1–4G4) and in nerves (Figures 4H1–4H4) of all
patients studied.
The ultrastructural characteristics of T1D, T1D+ESRD, and
KP groups compared with controls are represented in Figure 5.
The basal membrane of vessels was at least 3-fold thicker in T1D
(1986.36352.1 nm) and T1D+ESRD patients (2185.06330.4)
compared with controls (711.06172.3 nm) (p= 0.01 and p=0.02,
controls vs. T1D and T1D+ESRD, respectively) (Figures 5A–5D
and Table 4). The collapse of the lumen vessel was more evident in
the T1D group (2.060.4 AU) and T1D+ESRD (2.3603 AU)
compared with controls (0.560.2 AU) (p= 0.01 and p=0.001,
controls vs. T1D and T1D+ESRD, respectively) (Figures 5A–5D
and Table 4). Microvillar ramification was increased in
T1D+EDRD group (2.860.1 AU) compared with controls
(1.560.3 AU) (p = 0.03 controls vs. T1D+ESRD), (Figures 5A–
5D and Table 4). Endothelial cells of the T1D showed numerous
signs of damage as the presence of bundles of intermediate
filaments and pre-apoptotic nucleus (Figure 5B and Table 4).
Moreover, the cysternae of endoplasmic reticulum were slightly
Figure 5. Ultrastructural features of skin tissues. In the control group (A) the vessel lumen is correctly dilated and the endothelial cells are well
preserved showing Weibel-Palade granules (arrow). The basal membrane is thin (asterisk). In skin specimens from patients affected by type 1 diabetes
(T1D) (B), the vessel lumen is collapsed, endothelial cells show some degenerative markers, such as pre-apoptotic nuclei, dilated reticulum,
ramificated microvilli, and rare Weibel-Palade granules (arrow). The thickness of the basal membrane is also remarkable (asterisk). Skin from patients
with T1D and end-stage renal disease (T1D+ESRD) (C) showed endothelial cells with numerous signs of damage, including pre-apoptotic nuclei,
marked bundles of intermediate filaments, dilated cysternae of reticulum, ramificated microvilli, and very rare Weibel-Palade granules (arrow). In
addition, the basal membrane is very thick (asterisk). Skin from kidney-pancreas transplanted patients (KP) (D) showed reversal of almost all injury
features: the basal membrane less thick (asterisk), lightly collapsed lumen, rare microvillar ramification, and presence of Weibel-Palade granules
(arrow).
doi:10.1371/journal.pone.0009923.g005
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dilated and the Weibel-Palade granules were increased (Figure 5B
and Table 4). Interestingly, KP transplanted patients had a
marked improvement of almost all of these ultrastructural cell
features which were not statistically different from control subjects
(Figure 5D and Table 4). These findings confirm that KP
transplantation can modify even long-term established lesions in
T1D and T1D+ESRD patients and allow us to generate a close
link between these ultrastructural features and the reversal of
persistent changes at cellular levels.
Evaluation of oxidative stress
Malondialdehyde (MDA), widely used to monitor oxidative
stress [25], was evaluated in our four groups. T1D and
T1D+ESRD patients demonstrated an increase in total (p,0.01)
(Figure 6A), free (p,0.05 T1D vs. controls and p,0.01
T1D+ESRD vs. controls, respectively) (Figure 6B), and bound
MDA (p,0.01) (Figure 6C). The levels of total (ns), free (p,0.05),
and bound MDA (p,0.05) in KP transplant patients was
comparable or slightly increased compared with the control
group, indicating a profound effect of KP transplantation in
correcting increased oxidative stress (Figures 6A–6C). In contrast,
no significant differences were evident in GSH/GSSG (glutathi-
one and glutathione disulfide) ratio among the four groups
(Figures 6D–6F).
Pathway analysis
Proteins that were identified using MALDI-TOF MS analysis
were examined using PathwayAssist. The pathway was built by
looking for direct interactions of the down-regulated and up-
regulated proteins. The predominant cluster from this analysis is
depicted in Figure 7. Briefly, peptidyl-prolyl cis-trans isomerase A
(PPIA) and heat shock protein 27 kda (HSPB1) increase the
expression of superoxide dismutase-1 (SOD1), which regulates
catalase (CAT). SOD1 expression is under negative regulation by
CAT. In addition, common regulators for the up-regulated and
down-regulated proteins were analyzed with the assistance of
PathwayAssist. An examination of the up-regulated and down-
regulated proteins in T1D patients with and without ESRD is
shown in Figure 8. Heat shock protein 27 kda (HSPB1) and
superoxide dismutase-1 (SOD-1) are both central proteins in the
pathway analysis performed with the up-regulated list (Figure 8A).
SOD1 is regulated by a number of cytokine molecules, and
HSPB1 is directly associated with growth factors. Figure 8B shows
the common regulators for the down-regulated proteins observed
in this study. It is evident that CAT and crystal structures of
mutant K206A, chain A (TF) is a key protein that interacts with a
number of different signaling molecules in this pathway.
Discussion
In this study we employed several different techniques such as
proteomics, clinical biochemistry, electron microscopy, and immu-
nohistochemistry to identify pathways of persistent cellular changes
in skin biopsies of T1D patients. The effect of a KP transplant on
cellular pathways, protein expression, and ultrastructural features
was evaluated. We focused on the altered expression of several
proteins involved in oxidative stress, aerobic and anaerobic
glycolysis, and intracellular signaling normalized by KP transplant
and combined them in molecular/ultrastructural studies.
T1D patients showed an up-regulation of HSP60, HSP27,
MnSOD, and ATP synthase d chain with a further increase in
those patients with ESRD associated with T1D. This suggests that
HSP and anti-oxidative machinery is entirely altered and
thereafter restored by KP transplantation. These data are
consistent with previous studies indicating that transient exposure
of pancreatic islets to high glucose increases the activities of
antioxidant enzyme, such as Cu/Zn-SOD [25]. HSP60 and
HSP27 are synthesized in large amounts when cells are exposed to
stressful stimuli such as inflammation, infection, and exposure to
oxidizing agents [26,27,28,29]. We also identified down-regulation
of catalase, which has important antioxidant functions. Conse-
quently, there is decreased ability to counteract increased oxidative
stress in long-standing T1D. It has been reported that high levels
of glucose can produce permanent chemical alterations in
proteins, increase lipid peroxidation and production of free
radicals in several experimental models of hyperglycemia
[30,31]. In addition to the above-mentioned group of proteins,
proteomics data showed that long-standing T1D when associated
with ESRD also regulates cytoplasmic proteins involved in aerobic
and anaerobic glycolysis, gluconeogenesis, and mitochondrial
electron transport. Interestingly, T1D+ESRD patients who were
hyperglycemic and hyperinsulinemic also had increased triglycer-
ides, which are produced by anaerobic glycolysis and up-regulated
pyruvate kinase, while KP-transplanted patients were less dyslipi-
demic and presented lower pyruvate kinase levels than
T1D+ESRD patients comparable with controls [20,32]. T1D
patients were analogous to T1D+ESRD patients as far as the
Table 4. Quantification of ultrastructural features as evaluated on vessels obtained skin biopsies.
Controls T1D T1D+ESRD KP
Basal membrane thickness (nm) 711.06172.3 1986.36352.1* 2185.06330.4# 1292.06282.3
Collapsed vessel lumen (AU) 0.560.2 2.060.4o 2.360.3$ 1.160.1
Microvillar ramification (AU) 1.560.3 2.360.3 2.860.1oo 1.860.4
Reticulum cysternae dilatation (AU) 1.160.3 1.660.3 1.660.4 1.360.3
Intermediate filaments (AU) 2.560.3 3.060.3 2.060.3 2.560.2
Weibel Palade granules (AU) 2.860.1 2.860.1 2.360.3 2.360.3
Pre-apoptotic nuclei (AU) 1.560.3 1.660.3 2.360.2 2.360.3
T1D (type 1 diabetic patients).
*p = 0.01 and.
#p=0.002 compared with controls; T1D and T1D+ESRD (T1D+end-stage renal disease).
op = 0.01 and.
$p= 0.001 compared with controls; T1D+ESRD.
oop = 0.03 compared with controls; KP (kidney-pancreas transplanted patients); AU (arbitrary units).
doi:10.1371/journal.pone.0009923.t004
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expression of these three proteins, suggesting effect of T1D on
these pathways. The last identified altered expressed proteins
(stratifin, rotamase, S100 calcyclin) were involved in the
intracellular signaling pathway. Lee and co-workers suggested
[33] that rotamase may play a role in the folding of SOD-1 and in
its dimerization, possibly explaining the up-regulation of rotamase
in parallel to the up-regulation of SOD-1. In particular, this
association was related to a calcium-dependent pro-apoptotic
mechanism, and ultrastructural analysis emphasized the presence
of apoptotic nuclei both in T1D patients and in T1D+ESRD
patients.
Aiming to address if a parallel increase of redox state took place
in the periphery, we evaluated malondialdehyde (MDA), a
terminal compound derived from lipid peroxidation and from
eicosanoid biosynthesis, widely used to monitor oxidative stress
[25]. We measured both the free and the total MDA forms, the
first being considered an index of recent damage and the second
an index of prior damage. Therefore, we evaluated the levels of
Figure 6. Peripheral levels of total, free and bound malondialdehyde. Patients affected by type 1 diabetes (T1D) and T1D+ end-stage renal
disease (T1D+ESRD) demonstrated an increase in total (p,0.01) (A), free (p,0.05 T1D vs. controls and p,0.01 T1D+ESRD vs. controls, respectively)
(B), and bound malondialdehyde (MDA) (p,0.01) (C). The levels of total (ns), free (p,0.05), and bound MDA (p,0.05) in kidney-pancreas transplanted
patients (KP) was comparable to or slightly increased the control group, indicating a profound effect of kidney-pancreas transplantation in correcting
increased oxidative stress (A–C). In contrast, no significant differences were evident in the GSH/GSSG ratio among the four groups (D–F).
doi:10.1371/journal.pone.0009923.g006
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Figure 7. Proteins that were identified using MALDI-TOF MS analysis were examined using PathwayAssist. The pathway was built by
looking for direct interactions of the down-regulated and up-regulated proteins. The predominant cluster from this analysis is depicted in this figure.
Briefly, peptidyl-prolyl cis-trans isomerase A (PPIA) and heat shock protein 27 kda (HSPB1) increase the expression of superoxide dismutase-1 (SOD1),
which regulates catalase (CAT). SOD1 expression is under negative regulation by CAT.
doi:10.1371/journal.pone.0009923.g007
Figure 8. Common regulators for the up-regulated and down-regulated proteins were analyzed with the help of PathwayAssist.
Heat shock protein 27 kda (HSPB1) and superoxide dismutase-1 (SOD1) are both central proteins in the pathway analysis performed with the up-
regulated list (A). SOD1 is regulated by a number of cytokine molecules, and HSPB1 is directly associated with growth factors. Panel B shows the
common regulators for the down-regulated proteins observed in this study. It is evident that CAT and crystal structures of mutant K206A, chain A (TF)
is a key protein that interacts with a number of different signaling molecules in this pathway.
doi:10.1371/journal.pone.0009923.g008
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endogenous antioxidants such as GSH and GSSG. In T1D
patients, increased MDA levels in plasma were evident consistently
with the increased oxidative status than the controls, while KP-
transplanted patients presented lower MDA levels and were
comparable to the controls. We did not observe any differences in
GSH levels, which counteract the effect of free radicals. This is
consistent with a previous study from our group, which showed
that KP transplantation can reduce the levels of MDA [34].
The ultrastructural alterations found in T1D and T1D+ESRD
skin biopsies included thickening of the capillary basal membrane,
collapse of vessel lumen, and microvillar ramification. We
observed that basal membranes were thicker in T1D and
T1D+ESRD groups compared with controls, and that these
alterations were corrected in patients who had a KP transplant for
at least five years. We note that basal membrane thickening was
particularly evident in T1D+ESRD patients. The lumen of the
vessels was collapsed and microvilli were more branched in the
same group. Moreover, the T1D+ESRD group had an apoptotic
pattern of endothelial cells consistent with previous studies that
describe a role of hyperglycemia in inducing apoptosis in
endothelial cells [35]. All of these alterations were somehow more
evident in T1D+ESRD compared with T1D patients, possibly due
to the coexistence of two ‘‘toxic’’ situations, i.e., uremia and
hyperglycemia that may act additively. Skin biopsies from KP-
transplanted patients presented an impressive improvement of
ultrastructural alterations (basal membrane thickening, collapse of
vessel lumen, microvillar ramifications), as previously described in
kidney-transplanted patients who received islet transplantation
[36]. It is well known that hyperglycemia and diabetes induce
oxidative stress responses in animal models and cell culture
systems [37,38,39]. However, few studies have employed human
tissues to study the biochemistry of diabetic complications
[33,39,40,41]. The improvement of ultrastructural abnormalities
is consistent with what has been reported in the literature by Eberl
and co-workers, who showed that long-term blood glucose
normalization achieved by pancreas transplantation improved
most skin microcirculation parameters with a positive effect on
functionality of the skin [42].
These findings are consistent with the hypothesis that
hyperglycemia and uremia, through different mechanisms,
determine persistent cellular changes of the oxidative status and
pathways and that restoration of normoglycemia with KP
transplantation can correct most of these biochemical abnormal-
ities. To a lesser extent, T1D not associated with ESRD is also
characterized by an increase of oxidative stress. It is not clear if the
alterations of these pathways may determine alteration at
chromatin levels and altered DNA repairing. The next logical
step will be to evaluate the status of DNA damage during
the normalization of these pathways after kidney-pancreas
transplantation.
Some of these proteins or pathways addressed in our study may
become either biomarkers of oxidative stress in vivo or could be
potential therapeutic targets of a new class of drugs aimed at
correcting persistent cellular changes when normoglycemia cannot
be restored.
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